EMBRACE-SC: Observational Study of Subcutaneous (SC) Tocilizumab Alone or in Combination With Conventional Disease-Modifying Antirheumatic Drugs (cDMARDs) in Rheumatoid Arthritis
Clinical trial NCT02648035 · COMPLETED
Trial details
- NCT number
- NCT02648035
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-09-22
- Primary completion
- 2018-12-20
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.